# BioLife Sciences Inc. (BLFE)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BLFE/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2022 | $ 0 | $ -147 | $ -1 | $ 397 | $ -109 |
| 2021 | $ 0 | $ -414.1K | $ -113.9K | $ 425.7K | $ -835.7K |
| 2020 | $ 163.0K | $ -60.4K | N/A | N/A | N/A |
| 2019 | $ 0 | $ -60.6K | N/A | N/A | N/A |
| 2018 | $ 0 | $ -69.6K | N/A | N/A | N/A |
| 2017 | $ 0 | $ -472.8K | N/A | N/A | N/A |
| 2016 | $ 0 | $ -22.8K | N/A | N/A | N/A |
| 2008 | $ 4.96M | $ -1.95M | $ -687.7K | $ 2.86M | $ -418.6K |
| 2007 | $ 13.03M | $ -3.10M | $ -432.2K | $ 2.66M | $ 59.6K |
| 2006 | $ 9.88M | $ -298.1K | $ -74.2K | $ 2.42M | $ 250.4K |
| 2005 | $ 0 | $ -725.6K | $ -80.3K | $ 1.28M | $ 27.8K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -3.64 |
| Liabilities / Eq | -10.54 |
| Current Ratio | 0.07 |

## Other views

- [Metrics](https://sponda.capital/en/BLFE.md)
- [Charts](https://sponda.capital/en/BLFE/charts.md)
- [Compare](https://sponda.capital/en/BLFE/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.